CN Patent

CN102159285B — 作为hcv ns3蛋白酶抑制剂的大环喹喔啉化合物

Assigned to MSD Italia SRL · Expires 2014-05-14 · 12y expired

What this patent protects

本发明涉及式（I）的大环化合物及其作为丙型肝炎病毒（HCV）NS3蛋白酶抑制剂和用于治疗或预防HCV感染的用途。式（I）。

USPTO Abstract

本发明涉及式（I）的大环化合物及其作为丙型肝炎病毒（HCV）NS3蛋白酶抑制剂和用于治疗或预防HCV感染的用途。式（I）。

Drugs covered by this patent

Zepatier (ELBASVIR) · Merck & Co.

Patent Metadata

Patent number: CN102159285B
Jurisdiction: CN
Classification: —
Expires: 2014-05-14
Drug substance claim: No
Drug product claim: No
Assignee: MSD Italia SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.